| Literature DB >> 35527354 |
Robert Melvin1, Gerard M O'Reilly1, Andrew Underhill1, Larissa Stokes1, Sophie Tant1, Alison Look1.
Abstract
OBJECTIVE: The present study aims to describe presentations to the designated ED from the Victorian COVID-19 hotel quarantine program.Entities:
Keywords: COVID-19 < infectious disease; emergency medicine; emergency treatment < emergency medicine; transportation of patient < emergency medicine
Year: 2022 PMID: 35527354 PMCID: PMC9348087 DOI: 10.1111/1742-6723.14014
Source DB: PubMed Journal: Emerg Med Australas ISSN: 1742-6723 Impact factor: 2.279
Figure 1Incidence by month.
Demographics
| Characteristic | Number |
|---|---|
| Total number of ED presentations | 164 |
| Age (years), mean (SD) | 50.9 (17.5) |
| Sex (male) | 96 (58.5%) |
| Arrived from | |
| Airport | 34 (20.7%) |
| Complex care hotel | 36 (22.0%) |
| Health hotel | 8 (4.9%) |
| Maritime port | 3 (1.8%) |
| Quarantine hotel | 83 (50.6%) |
ED presentation characteristics
| Characteristic | Number |
|---|---|
| Triage category | |
| 1 | 0 (0.0%) |
| 2 | 21 (12.8%) |
| 3 | 88 (53.7%) |
| 4 | 49 (29.9%) |
| 5 | 6 (3.7%) |
| NZED classification primary complaint | |
| CNS | 15 (9.1%) |
| CVS | 33 (20.1%) |
| Eye | 5 (3.0%) |
| GI | 19 (11.6%) |
| GU | 1 (0.6%) |
| Head/neck | 3 (1.8%) |
| Mental health | 18 (11.0%) |
| Miscellaneous | 25 (15.2%) |
| MSK | 9 (5.5%) |
| Resp | 16 (9.8%) |
| Skin | 6 (3.7%) |
| Tox | 3 (1.8%) |
| Trauma/injury | 11 (6.7%) |
CNS, central nervous system; CVS, cardiovascular; GI, gastrointestinal; GU, genitourinary; MSK, musculoskeletal.
ED outcomes
| Characteristic | Number |
|---|---|
| Positive COVID‐19 PCR test (known or in ED) | 3 (1.8%) |
| Negative COVID‐19 PCR test in ED (or not swabbed) | 161 (98.1%) |
| Discharge destination | |
| Complex care hotel | 75 (45.7%) |
| Health hotel | 4 (2.4%) |
| Home | 2 (1.2%) |
| ICU | 4 (2.4%) |
| Maritime port | 1 (0.6%) |
| Quarantine hotel | 26 (15.9%) |
| Ward | 52 (31.7%) |
| Emergency care diagnosis groups | |
| E01 Nervous system and neurological | 5 (3.0%) |
| E02 Eye | 4 (2.4%) |
| E03 Ear, nose, mouth and throat | 3 (1.8%) |
| E04 Respiratory | 3 (1.8%) |
| E05 Circulatory | 27 (16.5%) |
| E06 Digestive | 6 (3.7%) |
| E07 Liver, gall bladder, bile duct and pancreas | 3 (1.8%) |
| E08 Musculoskeletal | 14 (8.5%) |
| E09 Skin, subcutaneous and breast tissue | 3 (1.8%) |
| E10 Endocrine, nutritional and metabolic | 5 (3.0%) |
| E11 Kidney and urinary tract | 9 (5.5%) |
| E12 Male genitourinary | 0 (0.0%) |
| E13 Gynaecology | 1 (0.6%) |
| E14 Obstetrics | 0 (0.0%) |
| E15 Perinatal | 0 (0.0%) |
| E16 Blood and immunology | 0 (0.0%) |
| E17 Neoplasms | 3 (1.8%) |
| E18 Infectious diseases | 18 (11.0%) |
| E19 Mental, behavioural and neurodevelopment | 25 (15.2%) |
| E20 Injuries and other externally caused morbidity | 18 (11.0%) |
| E50 General symptoms without diagnosis | 16 (9.8%) |
| E60 Other factors influencing health status | 1 (0.6%) |
ICU, intensive care unit; PCR, polymerase chain reaction.
Differences by primary outcome
| Characteristic | Admitted | Discharged | Odds ratio ([95% CI], |
|---|---|---|---|
| Total presentations | 56 | 108 | |
| Age (years), mean (SD) | 53.8 (16.9) | 49.4 (17.7) | 1.0 ([0.9, 1.0], 0.125) |
| Sex (female) | 21 (37.5%) | 47 (43.5%) | 0.8 ([0.4, 1.5], 0.459) |
| Triage category | |||
| 1 | 0 (0.0%) | 0 (0.0%) | N/A |
| 2 | 8 (14.3%) | 13 (12.0%) | N/A (reference group) |
| 3 | 31 (55.4%) | 57 (52.8%) | 0.9 ([0.3, 2.4], 0.805) |
| 4 | 14 (25.0%) | 35 (32.4%) | 0.6 ([0.2, 1.9], 0.433) |
| 5 | 3 (5.4%) | 3 (2.8%) | 1.6 ([0.3, 10.1], 0.602) |
| Arrived from | |||
| Airport | 17 (30.4%) | 17 (15.7%) | N/A (reference group) |
| Complex care hotel | 16 (28.6%) | 20 (18.5%) | 0.8 ([0.3, 1.9], 0.555) |
| Health hotel | 4 (7.1%) | 4 (3.7%) | 0.9 ([0.2, 4.4], 0.945) |
| Maritime port | 2 (3.6%) | 1 (0.9%) | N/A (reference group) |
| Quarantine hotel | 17 (30.4%) | 66 (61.1%) | 0.2 ([0.1, 0.6], 0.001) |
| NZED classification primary complaint | |||
| CVS | 5 (8.9%) | 28 (25.9%) | N/A (reference group) |
| GI | 10 (17.9%) | 9 (8.3%) | 6.2 ([1.7, 23.0], 0.006) |
| Mental health | 5 (8.9%) | 13 (12.0%) | 2.1 ([0.5, 8.8], 0.284) |
| MSK | 1 (1.8%) | 8 (7.4%) | 0.7 ([0.1, 6.9], 0.760) |
| Resp | 8 (14.3%) | 8 (7.4%) | 5.6 ([1.4, 21.9], 0.013) |
| Trauma/injury | 2 (3.6%) | 9 (8.3%) | 1.2 ([0.2, 7.5], 0.812) |
| Other (CNS, eye, GU, head/neck, miscellaneous, skin, tox) | 25 (44.6%) | 33 (30.5%) | 2.7 ([0.8, 8.5], 0.089) |
CVS, cardiovascular; GI, gastrointestinal.